Beranda › Lupus
Uji klinis Lupus yang merekrut di AS
73 studi untuk Lupus merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- New York City, NY18 studi
- Houston, TX13 studi
- Durham, NC12 studi
- Miami, FL10 studi
- Washington, DC10 studi
- Tampa, FL9 studi
- Philadelphia, PA9 studi
- Clearwater, FL8 studi
- Chicago, IL8 studi
- Boston, MA8 studi
- Santa Monica, CA8 studi
- Los Angeles, CA8 studi
- Buena Park, CA7 studi
- Memphis, TN7 studi
- Plantation, FL7 studi
- Charlotte, NC7 studi
- San Diego, CA7 studi
- Oklahoma City, OK7 studi
- Aurora, CO6 studi
- Dallas, TX6 studi
- Hollywood, FL6 studi
- Cedar Rapids, IA6 studi
- Atlanta, GA6 studi
- Fullerton, CA5 studi
- Cicero, IL5 studi
- Lake Charles, LA5 studi
- Jackson, TN5 studi
- New Orleans, LA5 studi
- St. Louis, MO5 studi
- Orlando, FL5 studi
- Syracuse, NY5 studi
- Cleveland, OH5 studi
- Flint, MI4 studi
- Frisco, TX4 studi
- San Francisco, CA4 studi
- Phoenix, AZ4 studi
- Kansas City, KS4 studi
- Charleston, SC4 studi
- Louisville, KY4 studi
- Salt Lake City, UT4 studi
Berdasarkan negara bagian
- Alabama5 studi
- Arizona7 studi
- California27 studi
- Colorado8 studi
- Distrik Columbia5 studi
- Florida23 studi
- Georgia9 studi
- Illinois14 studi
- Indiana4 studi
- Iowa6 studi
- Kansas5 studi
- Kentucky4 studi
- Louisiana9 studi
- Maryland10 studi
- Massachusetts9 studi
- Michigan10 studi
- Minnesota5 studi
- Missouri8 studi
- Nebraska3 studi
- New Jersey6 studi
- New York26 studi
- North Carolina20 studi
- Ohio11 studi
- Oklahoma7 studi
- Pennsylvania14 studi
- South Carolina5 studi
- Tennessee13 studi
- Texas26 studi
- Utah4 studi
- Virginia3 studi
- Washington5 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Menerima pesertaFase 3
Usia 12 hingga 100 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06133972Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Menerima pesertaFase 2
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07409181An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Menerima pesertaFase 3
Usia 5 hingga 17 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05835310Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Wanita · Diperbarui 28 Sep 2026 · NCT05567198A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
Menerima pesertaFase 1
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07607964CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
Menerima pesertaFase 1/2
Usia 10 hingga 29 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT06839976Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345Anifrolumab Pregnancy Study
Menerima pesertaStudi observasional
Usia 18 hingga 130 · Wanita · Diperbarui 18 Sep 2026 · NCT07049653The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05440422Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07201558Transcutaneous Vagus Nerve Stimulation in SLE
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06987565A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis
Menerima pesertaFase 2
Usia 16 hingga 70 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07328581Study of Systemic Lupus Erythematosus
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 3 hingga 120 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT00001372Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
Menerima pesertaFase 4
Usia 18 hingga 130 · Wanita · Diperbarui 16 Sep 2026 · NCT06594068HEALTH Home Urinalysis Testing
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07823478A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Menerima pesertaFase 1
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06916806A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07355218Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Menerima pesertaFase 1
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT06975787A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
Menerima pesertaFase 2
Usia 12 hingga 70 · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07570862A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07332481A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Menerima pesertaFase 1
Usia 18 hingga 74 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07085104A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
Menerima pesertaFase 1/2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06897930Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.